NRBO Rentabilitas operasi NeuroBo Pharma

NRBO (NeuroBo Pharmaceuticals) - tandha merek perusahaan

NeuroBo Pharmaceuticals generates revenue through partnerships in the development of drugs for liver pathologies, obesity, and neurodegeneration. The adjusted operating margin allows for an assessment of these processes' dynamics, while 0.00 indicates the current level. Innovative molecules for the therapy of metabolic disorders with long-term patent protection establish the foundation for future revenues. Currently, NeuroBo Pharmaceuticals is focused on clinical trials of cardiometabolic drugs without the presence of stable cash flows.

neurobopharma.com (NRBO): Margin dodolan operasi saka 04.07.2022 nganti 07.12.2024

Rincian analitis perusahaan NeuroBo Pharmaceuticals

Analisis fundamental perusahaan:NeuroBo Pharmaceuticals Inc
Produk dadi NeuroBo Pharma

The NeuroBo Pharmaceuticals (NRBO) business model focuses on the commercialization of metabolic disorder therapies, with primary expenditures directed toward the development of obesity and MASH drugs. An analysis of the operating profit margin allows for an assessment of expense management efficiency before taxes and interest, while the low values on this chart for small-cap companies often reflect a phase of aggressive R&D investment.

Pesaing utama

Margin dodolan operasi BIIB|NBIX: Tingkat bathi operasi|Rentabilitas operasi Regencell Bioscience Ltd (RGC)|Margin operasi axsome.com (AXSM)|Margin operasi ACAD (acadia-pharm.com)|XENE - Margin dodolan operasi|vikingtherapeutics.com - Margin operasi|Supernus Pharma (SUPN) - Margin dodolan operasi|CPRX: Margin operasi|Denali Therapeutics Inc. (DNLI) - Margin operasi|Rentabilitas operasi Harmony Pharma|Rentabilitas operasi BHVN|Margin dodolan operasi AMLX (Amylyx Pharmaceuticals, Inc.)|Margin dodolan operasi Trevi Corp TRVI|Rentabilitas operasi praxismedicines.com PRAX|AVXL - Margin dodolan operasi|CeriBell EEG - Margin operasi|Rentabilitas dodolan operasi prothena.com|Alector Therapeutics (ALEC) - Rentabilitas operasi|Annexon Biosciences Inc. - Tingkat bathi operasi|OMER (Omeros Corp) - Margin operasi|Margin operasi neurogene.com|Margin operasi ACIU|VYGR - Rentabilitas dodolan operasi|Rentabilitas operasi Neumora Therapeutics Inc NMRA|Rentabilitas kegiatan operasi Scilex Holding Co. (SCLX)|TVGN - Rentabilitas operasi|Rentabilitas dodolan operasi alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Margin dodolan operasi|IKT: Rasio bathi operasi|Rentabilitas operasi Cassava Sciences, Inc.|ASRT (assertiotx.com) - Rasio bathi operasi|Rentabilitas operasi Coya (COYA)|VTGN - Rentabilitas dodolan operasi|Margin operasi OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Rentabilitas dodolan operasi|cervomed.com - Margin operasi|Tingkat bathi operasi ATHE (Alterity Therapeutics Limited)|CLNN: Margin operasi|Margin dodolan operasi PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Margin operasi|Rentabilitas dodolan operasi Relmada Therapeutics Inc RLMD|Rentabilitas operasi Annovis Bio Corporation (ANVS)|GRCE - Rentabilitas dodolan operasi|Rentabilitas operasi Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Rentabilitas dodolan operasi|NeuroSense Therapeutics, Ltd. - Margin operasi|RVPH: Rentabilitas operasi|MTVA: Margin operasi|NRXS - Rentabilitas kegiatan operasi|HSDT (Helius Medical Technologies Inc.) - Margin operasi|Rentabilitas dodolan operasi Passage Bio PASG|Rentabilitas operasi Neuphoria (NEUP)|Margin operasi Minerva Neurosciences Corp (NERV)|Rentabilitas operasi Athira ATHA|Margin operasi Addex ADXN|Alzamend - Margin operasi|Rentabilitas dodolan operasi Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Rentabilitas operasi|KTTA: Rasio bathi operasi|Margin dodolan operasi CRGT|Avenue Therapeutics, Inc - Margin bathi operasi|Rentabilitas operasi Brainstorm Cell (BCLI)|CARA: Margin bathi operasi|Chromocell Therapeutics Corp. - Margin dodolan operasi|Rentabilitas kegiatan operasi Eliem (ELYM)|ITCI: Margin dodolan operasi|Tingkat bathi operasi LBPH (Longboard)|marinuspharma.com (MRNS) - Rentabilitas operasi|NKGN - Rentabilitas kegiatan operasi|SAGE (Sage Therapeutics Inc.) - Margin operasi|Neurotrope - Margin bathi operasi|Margin operasi TRVN|Rentabilitas kegiatan operasi Vigil Neuroscience, Inc.|Rentabilitas operasi Anew Medical, Inc. WENA|CERE - Margin dodolan operasi